eXoZymes, Inc.
Ownership
Ownership Structure
Who owns eXoZymes, Inc. (EXOZ)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.3% of the shares are freely tradable; institutional investors hold 0.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 0.59 | 54,985 | +147.8 | 06/30/2026 |
| Davidson Kahn Capital Management, LLC | 0.27 | 25,000 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 0.25 | 23,406 | +6.9 | 06/30/2026 |
| BlackRock Inc | 0.10 | 9,610 | +41.4 | 06/30/2026 |
| Vanguard Fiduciary Trust Co | 0.10 | 9,426 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 0.93 | 86,390 | +0.0 | 09/30/2026 |
| Fidelity Extended Market Index | 0.13 | 11,726 | -0.5 | 08/31/2026 |
| iShares Micro-Cap ETF | 0.12 | 10,947 | -0.7 | 09/30/2026 |
| Fidelity Series Total Market Index | 0.03 | 2,944 | +0.0 | 08/31/2026 |
| Fidelity Total Market Index | 0.02 | 2,018 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Korman Tyler Paz | Chief Scientific Officer | 762,837 | 3,356,483 $ | Aug 19, 2026 | direct |
| Perriman Damien Alan | Chief Commercial Officer | 28,692 | 126,245 $ | Oct 12, 2026 | direct |
| Heltzen Michael | Chief Executive Officer | 14,453 | 63,593 $ | Aug 26, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Perriman Damien Alan | Chief Commercial Officer | Sell | 3,729 | 5.21 | 19,427 |
| Oct 9, 2026 | Perriman Damien Alan | Chief Commercial Officer | Other | 3,922 | – | – |
| Aug 26, 2026 | Heltzen Michael | Chief Executive Officer | Buy | 250 | 7.60 | 1,900 |
| Aug 26, 2026 | Heltzen Michael | Chief Executive Officer | Buy | 251 | 7.35 | 1,845 |
| Aug 26, 2026 | Heltzen Michael | Chief Executive Officer | Buy | 4 | 7.58 | 30 |
| Aug 25, 2026 | Heltzen Michael | Chief Executive Officer | Buy | 100 | 7.50 | 750 |
| Aug 25, 2026 | Heltzen Michael | Chief Executive Officer | Buy | 250 | 7.52 | 1,880 |
| Aug 19, 2026 | Heltzen Michael | Chief Executive Officer | Other | 8,841 | 6.40 | 56,582 |
| Aug 19, 2026 | Perriman Damien Alan | Chief Commercial Officer | Other | 19,612 | – | – |
| Aug 19, 2026 | Korman Tyler Paz | Chief Scientific Officer | Other | 32,964 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.